Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 87

1.

Individualizing immunosuppression in lung transplantation.

McDermott JK, Girgis RE.

Glob Cardiol Sci Pract. 2018 Mar 14;2018(1):5. doi: 10.21542/gcsp.2018.5. Review.

2.

Lung transplantation in idiopathic pulmonary fibrosis.

Kumar A, Kapnadak SG, Girgis RE, Raghu G.

Expert Rev Respir Med. 2018 May;12(5):375-385. doi: 10.1080/17476348.2018.1462704. Epub 2018 Apr 20. Review.

PMID:
29621919
3.

The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study.

Sato T, Ambale-Venkatesh B, Lima JAC, Zimmerman SL, Tedford RJ, Fujii T, Hulme OL, Pullins EH, Corona-Villalobos CP, Zamanian RT, Minai OA, Girgis RE, Chin K, Khair R, Damico RL, Kolb TM, Mathai SC, Hassoun PM.

Pulm Circ. 2018 Jan-Mar;8(1):2045893217748307. doi: 10.1177/2045893217748307. Epub 2017 Dec 18.

4.

Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.

Mercurio V, Mukherjee M, Tedford RJ, Zamanian RT, Khair RM, Sato T, Minai OA, Torres F, Girgis RE, Chin K, Damico R, Kolb TM, Mathai SC, Hassoun PM.

Am J Respir Crit Care Med. 2018 Feb 1;197(3):388-391. doi: 10.1164/rccm.201704-0789LE. No abstract available.

5.

Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation in Patients Over Age 70 Years: A Case Report.

Hayanga JA, Murphy E, Girgis RE, Jansma S, Khaghani A.

Transplant Proc. 2017 Jan - Feb;49(1):218-220. doi: 10.1016/j.transproceed.2016.11.025.

PMID:
28104142
6.

Exhaled nitric oxide in pulmonary arterial hypertension associated with systemic sclerosis.

Cao Z, Mathai SC, Hummers LK, Shah AA, Wigley FM, Lechtzin N, Hassoun PM, Girgis RE.

Pulm Circ. 2016 Dec;6(4):545-550. doi: 10.1086/688768.

7.

A global perspective of lung transplantation: Part 1 - Recipient selection and choice of procedure.

Girgis RE, Khaghani A.

Glob Cardiol Sci Pract. 2016 Mar 31;2016(1):e201605. doi: 10.21542/gcsp.2016.5. Review.

8.

Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension.

Al-Naamani N, Palevsky HI, Lederer DJ, Horn EM, Mathai SC, Roberts KE, Tracy RP, Hassoun PM, Girgis RE, Shimbo D, Post WS, Kawut SM; ASA-STAT Study Group.

Ann Am Thorac Soc. 2016 Jan;13(1):25-30. doi: 10.1513/AnnalsATS.201508-543OC.

9.

Implantable atrial flow regulator for severe, irreversible pulmonary arterial hypertension.

Patel MB, Samuel BP, Girgis RE, Parlmer MA, Vettukattil JJ.

EuroIntervention. 2015 Oct;11(6):706-9. doi: 10.4244/EIJY15M07_08.

10.

Bidimensional measurements of right ventricular function for prediction of survival in patients with pulmonary hypertension: comparison of reproducibility and time of analysis with volumetric cardiac magnetic resonance imaging analysis.

Corona-Villalobos CP, Kamel IR, Rastegar N, Damico R, Kolb TM, Boyce DM, Sager AE, Skrok J, Shehata ML, Vogel-Claussen J, Bluemke DA, Girgis RE, Mathai SC, Hassoun PM, Zimmerman SL.

Pulm Circ. 2015 Sep;5(3):527-37. doi: 10.1086/682229.

11.

Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.

Hassoun PM, Zamanian RT, Damico R, Lechtzin N, Khair R, Kolb TM, Tedford RJ, Hulme OL, Housten T, Pisanello C, Sato T, Pullins EH, Corona-Villalobos CP, Zimmerman SL, Gashouta MA, Minai OA, Torres F, Girgis RE, Chin K, Mathai SC.

Am J Respir Crit Care Med. 2015 Nov 1;192(9):1102-10. doi: 10.1164/rccm.201507-1398OC.

12.

Transcatheter intervention in cor triatriatum sinister.

Patel MB, Samuel BP, Berjaoui WK, Girgis RE, Vettukattil JJ.

Can J Cardiol. 2015 Jun;31(6):819.e3-4. doi: 10.1016/j.cjca.2015.01.036. Epub 2015 Feb 4.

PMID:
26022992
13.

[Updated treatment algorithm of pulmonary arterial hypertension].

Galiè N, Corris PA, Frost A, Girgis RE, Granton J, Jing ZC, Klepetko W, McGoon MD, McLaughlin VV, Preston IR, Rubin LJ, Sandoval J, Seeger W, Keogh A.

Turk Kardiyol Dern Ars. 2014 Oct;42 Suppl 1:78-94. Turkish.

14.

Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertension.

Matura LA, Ventetuolo CE, Palevsky HI, Lederer DJ, Horn EM, Mathai SC, Pinder D, Archer-Chicko C, Bagiella E, Roberts KE, Tracy RP, Hassoun PM, Girgis RE, Kawut SM.

Ann Am Thorac Soc. 2015 Mar;12(3):370-5. doi: 10.1513/AnnalsATS.201410-463OC.

15.

Serial monitoring of exhaled nitric oxide in lung transplant recipients.

Gashouta MA, Merlo CA, Pipeling MR, McDyer JF, Hayanga JW, Orens JB, Girgis RE.

J Heart Lung Transplant. 2015 Apr;34(4):557-62. doi: 10.1016/j.healun.2014.09.026. Epub 2014 Nov 6.

16.

Severity of systemic sclerosis-associated pulmonary arterial hypertension in African Americans.

Blanco I, Mathai S, Shafiq M, Boyce D, Kolb TM, Chami H, Hummers LK, Housten T, Chaisson N, Zaiman AL, Wigley FM, Tedford RJ, Kass DA, Damico R, Girgis RE, Hassoun PM.

Medicine (Baltimore). 2014 Jul;93(5):177-85. doi: 10.1097/MD.0000000000000032.

17.

Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom.

Gladwin MT, Barst RJ, Gibbs JS, Hildesheim M, Sachdev V, Nouraie M, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, Novelli E, Girgis RE, Morris CR, Berman Rosenzweig E, Badesch DB, Lanzkron S, Castro OL, Taylor JG 6th, Goldsmith JC, Kato GJ, Gordeuk VR, Machado RF; walk-PHaSST Investigators and Patients.

PLoS One. 2014 Jul 2;9(7):e99489. doi: 10.1371/journal.pone.0099489. eCollection 2014.

18.

Updated treatment algorithm of pulmonary arterial hypertension.

Galiè N, Corris PA, Frost A, Girgis RE, Granton J, Jing ZC, Klepetko W, McGoon MD, McLaughlin VV, Preston IR, Rubin LJ, Sandoval J, Seeger W, Keogh A.

J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D60-72. doi: 10.1016/j.jacc.2013.10.031. Review.

19.

Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension.

Tedford RJ, Mudd JO, Girgis RE, Mathai SC, Zaiman AL, Housten-Harris T, Boyce D, Kelemen BW, Bacher AC, Shah AA, Hummers LK, Wigley FM, Russell SD, Saggar R, Saggar R, Maughan WL, Hassoun PM, Kass DA.

Circ Heart Fail. 2013 Sep 1;6(5):953-63.

20.

Genetic determinants of haemolysis in sickle cell anaemia.

Milton JN, Rooks H, Drasar E, McCabe EL, Baldwin CT, Melista E, Gordeuk VR, Nouraie M, Kato GR, Minniti C, Taylor J, Campbell A, Luchtman-Jones L, Rana S, Castro O, Zhang Y, Thein SL, Sebastiani P, Gladwin MT; Walk-PHAAST Investigators, Steinberg MH.

Br J Haematol. 2013 Apr;161(2):270-8. doi: 10.1111/bjh.12245. Epub 2013 Feb 14. Erratum in: Br J Haematol. 2014 Aug;166(3):468. Kato, Gregory R [corrected to Kata, Gregory J]. Br J Haematol. 2014 Aug;166(3):468.

Supplemental Content

Loading ...
Support Center